1-3 of 3
Jonathan M. Gall
Close
Sort by
Journal Articles

Immunotherapy of Primary Ovarian Cancer Using Autologous Cytokine Induced Killer Cells Retargeted with Bispecific Antibodies: A Preclinical Study.

John K. Chan, MD, Chad A. Hamilton, MD, Michael K. Cheung, BA, Mobin Karimi, MS, Jeanette Baker, PhD, Jonathan M. Gall, BA, Lawrence G. Lum, MD, Stephan Schulz, MD, Steve H. Thorne, PhD, Nelson N. Teng, MD, PhD, Christopher H. Contag, PhD, Robert S. Negrin, MD
Journal: Blood
Blood (2005) 106 (11): 2379.
https://doi.org/10.1182/blood.V106.11.2379.2379
Published: 2005
Journal Articles

Human Stem Cells Armed with Bispecific Antibodies Home to Injury-Specific Molecules in Myocardial Infarcts in Nude Rats.

Lawrence G. Lum, MD, DSc, Pamela A. Davol, MEd, Richard E. Sievers, Ryan C. Grabert, Qizhi Fang, MD, Jonathan M. Gall, Michael S. Yee, James W. Larrick, MD, PhD, Randall J. Lee, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2697.
https://doi.org/10.1182/blood.V104.11.2697.2697
Published: 2004
Journal Articles

Infusions of T Cells Armed with Anti-CD3 x Anti-Her2/neu Bispecific Antibody Modulate In Vivo Patient Immune Responses in Phase I Clinical Trials for Breast and Hormone Refractory Prostate Cancers.

Pamela A. Davol, MEd, Jonathan M. Gall, BS, Ryan C. Grabert, BS, Wendy B. Young, RN, OCN, Francis J. Cummings, MD, Ritesh Rathore, MD, Gerald A. Colvin, DO, Gerald J. Elfenbein, MD, Lawrence G. Lum, MD, DSc
Journal: Blood
Blood (2004) 104 (11): 1349.
https://doi.org/10.1182/blood.V104.11.1349.1349
Published: 2004